A phase II randomized trial of metastasis-directed therapy with alpha emitter radium-223 in men with oligometastatic castration-resistant prostate cancer (MEDAL)
一项针对寡转移性去势抵抗性前列腺癌男性患者的转移定向治疗的 II 期随机试验(MEDAL)
期刊:BMC Urology
影响因子:1.9
doi:10.1186/s12894-023-01202-z
Yoshida, Soichiro; Takahara, Taro; Arita, Yuki; Ito, Masaya; Hayakawa, Sara; Oguchi, Tomohiko; Komai, Yoshinobu; Numao, Noboru; Yuasa, Takeshi; Inoue, Masaharu; Ushijima, Hiroki; Kudo, Shigehiro; Shimano, Yasumasa; Nakamura, Yuki; Uchida, Yusuke; Uehara, Sho; Tanaka, Hajime; Yaegashi, Hiroshi; Izumi, Kouji; Yokoyama, Minato; Matsuoka, Yoh; Yoshioka, Yasuo; Konishi, Koji; Nakanishi, Katsuyuki; Nagahara, Akira; Hirakawa, Akihiro; Koike, Ryuji; Koga, Fumitaka; Nishimura, Kazuo; Mizokami, Atsushi; Yonese, Junji; Kageyama, Yukio; Yoshimura, Ryoichi; Fujii, Yasuhisa